Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
bromocriptine
bromocriptine, slow release
dopamine agonist
Parkinson disease
Parkinson disease, treatment of
treatment of neurologic disorder
Showing articles 300 to 350 of 448 << Previous Next >>

Irradiation of Meningiomas of the Intracranial Anterior Visual Pathway
Ann Neurol 21:131-137, Kupersmith,M.J.,et al, 1987

Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987

Controlled-Release Levodopa/Carbidopa. I. Sinemet CR3 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:233-241, Cedarbaum,J.M.,et al, 1987

Controlled Release Levodopa Treatment of Motor Fluctuations in Parkinson's Disease
JNNP 50:194-198, Juncos,J.L.,et al, 1987

Platelet Deposition at Carotid Endarterectomy Sites in Humans
Stroke 18:722-727, Stratton,J.R.,et al, 1987

Hypercoagulability in Acute Stroke:Prognostic Significance
Neurol 37:1667-1671, Landi,G.,et al, 1987

The Neurologic Examination in Patients with Probable Alzheimer's Disease
Arch Neurol 44:929-932, Huff,F.J.,et al, 1987

Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987

Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987

Anterior Ischaemic Optic Neuropathy in the Acquired Immune Deficiency Syndrome
BMJ 295:696-697, Brack,M.J.,et al, 1987

Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987

Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987

Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987

Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987

Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987

Aneurysmal Compression of the Anterior Visual Pathways
Neurol 36:1035-1041, Norwood,E.G.,et al, 1986

Vascular Retinopathy in Migraines
Neurol 36:267-270, Coppeto,F.R.,et al, 1986

Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986

Giant Axonal Neuropathy:Central Abnormalities Demonstrated by Evoked Potentials
Ann Neurol 19:394-396, Majnemer,A.,et al, 1986

Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986

Gradual Loss & Recovery of Vision in Temporal Arteritis
Arch Int Med 145:2252-2253, Lipton,R.B.,et al, 1985

Neurologic Signs in Senescence
Arch Neurol 42:1154-1157, Jenkyn,L.R.,et al, 1985

Early Neurological Complications of Coronary Artery Bypass Surgery
BMJ 291:1384-1387, Shaw,P.J.,et al, 1985

Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985

Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

Delayed Cerebral Ischemia Following Arteriography
Stroke 16:431-434, Fisher,M.,et al, 1985

Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985

Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985

Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985

Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985

Acute Ethanol Ingestion Increases Platelet Reactivity:Is There a Relationship to Stroke
Stroke 16:19-23, Hillbom,M.,et al, 1985

Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984

Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984

Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984

Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984

Clinicopathological Conference Metachromatic Leukodystrophy (juvenile type)
Case 7-1984, NEJM 310:445-4551984., , 1984

Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984

Indirect Injury of the Optic Nerve
Neurosurgery 14:756-764, Kline,L.B.,et al, 1984

Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983

Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983

Glutamate Dehydrogenase Deficiency in Patients with Olivopontocerebellar Atrophy
Neurol 33:1322-1326, Duvoisin,R.C.,et al, 1983

Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983

Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983

Bilateral Optic Neuropathy with Remission in Young Men, Variation on a Theme by Leber
Arch Neurol 40:2-6, Lessell,S.,et al, 1983

Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983

Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983

Sexual Automatisms in Complex Partial Seizures
Neurol 33:527-533, Spencer,S.S.,et al, 1983



Showing articles 300 to 350 of 448 << Previous Next >>